CISD2
Basic information
Region (hg38): 4:102868974-102892807
Previous symbols: [ "ZCD2", "WFS2" ]
Links
Phenotypes
GenCC
Source:
- Wolfram syndrome 2 (Strong), mode of inheritance: AR
- Wolfram syndrome 2 (Strong), mode of inheritance: AR
- Wolfram syndrome 2 (Strong), mode of inheritance: AR
- Wolfram syndrome 2 (Moderate), mode of inheritance: AR
- Wolfram syndrome (Supportive), mode of inheritance: AR
- Wolfram syndrome 2 (Strong), mode of inheritance: AR
- Wolfram syndrome (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Wolfram syndrome 2 | AR | Gastrointestinal; Genitourinary; Hematologic; Renal | Urinary tract anomalies can lead to severe (and potentially avoidable) renal sequelae, including renal failure, and surveillance and early management can be beneficial; Surveillance for and early treatment of bleeding diatheses (as well as related GI disease that can lead to bleeding) can be beneficial | Audiologic/Otolaryngologic; Endocrine; Gastrointestinal; Genitourinary; Hematologic; Ophthalmologic; Renal | 10739754; 11317648; 12116178; 17846994; 22790102; 23429432; 25056293 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CISD2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 17 | 17 | ||||
missense | 16 | 16 | ||||
nonsense | 0 | |||||
start loss | 1 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 15 | 16 | ||||
Total | 0 | 0 | 17 | 32 | 1 |
Variants in CISD2
This is a list of pathogenic ClinVar variants found in the CISD2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-102869053-G-A | not specified | Likely benign (Dec 15, 2017) | ||
4-102869087-G-A | Wolfram syndrome 2 | Uncertain significance (Sep 01, 2022) | ||
4-102869094-G-C | Inborn genetic diseases | Uncertain significance (Jul 20, 2021) | ||
4-102869096-G-A | CISD2-related disorder | Conflicting classifications of pathogenicity (Jan 15, 2024) | ||
4-102869103-G-A | Uncertain significance (Jul 06, 2022) | |||
4-102869105-C-T | Likely benign (Sep 10, 2023) | |||
4-102869132-A-C | Likely benign (Jan 18, 2024) | |||
4-102869136-C-T | Likely benign (Jan 31, 2024) | |||
4-102869144-G-C | Wolfram syndrome 2 | Benign/Likely benign (Dec 23, 2023) | ||
4-102869167-C-T | Wolfram syndrome 2 | Uncertain significance (Jul 10, 2023) | ||
4-102869168-C-G | Likely benign (Jun 15, 2022) | |||
4-102869176-C-T | Uncertain significance (Nov 04, 2020) | |||
4-102869188-G-A | Wolfram syndrome 2 | Pathogenic (Jul 30, 2019) | ||
4-102869192-T-G | CISD2-related disorder | Uncertain significance (Apr 12, 2022) | ||
4-102869193-C-A | Wolfram syndrome 2 | Uncertain significance (Feb 05, 2022) | ||
4-102869196-C-T | Likely benign (Aug 04, 2023) | |||
4-102869199-C-G | Likely benign (Jun 29, 2023) | |||
4-102869199-C-T | Likely benign (Jan 02, 2022) | |||
4-102869200-C-T | Likely benign (Sep 15, 2023) | |||
4-102869201-A-C | Likely benign (Jan 31, 2023) | |||
4-102869203-C-G | Likely benign (Jul 19, 2023) | |||
4-102874540-C-G | Likely benign (May 01, 2023) | |||
4-102885206-A-G | Likely benign (Jul 25, 2022) | |||
4-102885207-C-A | Wolfram syndrome 2 • CISD2-related disorder | Benign/Likely benign (Dec 12, 2023) | ||
4-102885221-G-C | Wolfram syndrome 2 | Pathogenic (Oct 01, 2007) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CISD2 | protein_coding | protein_coding | ENST00000273986 | 3 | 20265 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.416 | 0.552 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.27 | 42 | 72.4 | 0.580 | 0.00000398 | 870 |
Missense in Polyphen | 21 | 31.705 | 0.66236 | 353 | ||
Synonymous | -0.659 | 32 | 27.6 | 1.16 | 0.00000145 | 266 |
Loss of Function | 1.71 | 1 | 5.20 | 0.192 | 2.19e-7 | 67 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Regulator of autophagy that contributes to antagonize BECN1-mediated cellular autophagy at the endoplasmic reticulum. Participates in the interaction of BCL2 with BECN1 and is required for BCL2-mediated depression of endoplasmic reticulum Ca(2+) stores during autophagy. Contributes to BIK-initiated autophagy, while it is not involved in BIK-dependent activation of caspases. Involved in life span control, probably via its function as regulator of autophagy. {ECO:0000269|PubMed:17846994, ECO:0000269|PubMed:20010695}.;
Recessive Scores
- pRec
- 0.110
Intolerance Scores
- loftool
- 0.215
- rvis_EVS
- -0.05
- rvis_percentile_EVS
- 49.39
Haploinsufficiency Scores
- pHI
- 0.186
- hipred
- Y
- hipred_score
- 0.545
- ghis
- 0.556
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.181
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cisd2
- Phenotype
- cellular phenotype; homeostasis/metabolism phenotype; craniofacial phenotype; muscle phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; skeleton phenotype; renal/urinary system phenotype; vision/eye phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; pigmentation phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype;
Gene ontology
- Biological process
- autophagy of mitochondrion;multicellular organism aging;regulation of autophagy
- Cellular component
- mitochondrial outer membrane;endoplasmic reticulum;endoplasmic reticulum membrane;membrane;integral component of membrane;protein-containing complex;perinuclear endoplasmic reticulum
- Molecular function
- RNA binding;protein binding;protein homodimerization activity;metal ion binding;2 iron, 2 sulfur cluster binding